Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)

NCT02593045 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma

Interventions

BIOLOGICAL: IPH4102

Sponsor

Innate Pharma